Clinical Trial Update: BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BOL-303259-X with Timolol 0.5% in subjects with open-angle glaucoma or ocular hypertension has completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• BOL-303259-X
• Timolol 0.5% (timolol)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2018-09-04